CEGEDIM SA (ALCGM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALCGM - FR0000053506 - Common Stock
13.5 EUR
+0.15 (+1.12%)
Taking everything into account, ALCGM scores 2 out of 10 in our fundamental rating. ALCGM was compared to 10 industry peers in the Health Care Technology industry. ALCGM may be in some trouble as it scores bad on both profitability and health. ALCGM has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ALCGM had negative earnings in the past year.
In the past year ALCGM had a positive cash flow from operations.
In multiple years ALCGM reported negative net income over the last 5 years.
Each year in the past 5 years ALCGM had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.44%, ALCGM is doing worse than 60.00% of the companies in the same industry.
ALCGM has a Return On Equity of -5.34%. This is in the lower half of the industry: ALCGM underperforms 60.00% of its industry peers.
The Return On Invested Capital of ALCGM (5.25%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ALCGM is significantly below the industry average of 9.28%.
The 3 year average ROIC (2.87%) for ALCGM is below the current ROIC(5.25%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.44% | ||
| ROE | -5.34% | ||
| ROIC | 5.25% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
1.3 Margins
Looking at the Operating Margin, with a value of 6.75%, ALCGM is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ALCGM has declined.
With a Gross Margin value of 20.65%, ALCGM is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
ALCGM's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.65% |
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALCGM is still creating some value.
ALCGM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALCGM has less shares outstanding
The debt/assets ratio for ALCGM is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.31, we must say that ALCGM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.31, ALCGM is doing worse than 60.00% of the companies in the same industry.
ALCGM has a debt to FCF ratio of 5.89. This is a neutral value as ALCGM would need 5.89 years to pay back of all of its debts.
ALCGM has a Debt to FCF ratio (5.89) which is in line with its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that ALCGM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.11, ALCGM is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 5.89 | ||
| Altman-Z | 1.31 |
ROIC/WACC1.06
WACC4.94%
2.3 Liquidity
ALCGM has a Current Ratio of 0.93. This is a bad value and indicates that ALCGM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.93, ALCGM is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.91 indicates that ALCGM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.91, ALCGM is doing worse than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for ALCGM have decreased strongly by -796.49% in the last year.
ALCGM shows a small growth in Revenue. In the last year, the Revenue has grown by 3.79%.
Measured over the past years, ALCGM shows a small growth in Revenue. The Revenue has been growing by 5.38% on average per year.
EPS 1Y (TTM)-796.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%
3.2 Future
The Earnings Per Share is expected to grow by 22.06% on average over the next years. This is a very strong growth
ALCGM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.41% yearly.
EPS Next Y-1.48%
EPS Next 2Y20.35%
EPS Next 3Y22.06%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALCGM. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.01, the valuation of ALCGM can be described as reasonable.
Based on the Price/Forward Earnings ratio, ALCGM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, ALCGM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.01 |
4.2 Price Multiples
ALCGM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALCGM is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALCGM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.49 | ||
| EV/EBITDA | 3.16 |
4.3 Compensation for Growth
ALCGM's earnings are expected to grow with 22.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.35%
EPS Next 3Y22.06%
5. Dividend
5.1 Amount
ALCGM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALCGM (12/30/2025, 7:00:00 PM)
13.5
+0.15 (+1.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners14.5%
Inst Owner ChangeN/A
Ins Owners57.78%
Ins Owner ChangeN/A
Market Cap190.35M
Revenue(TTM)658.00M
Net Income(TTM)-14.16M
Analysts44.44
Price Target12.92 (-4.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.01 | ||
| P/S | 0.29 | ||
| P/FCF | 3.49 | ||
| P/OCF | 1.4 | ||
| P/B | 0.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.16 |
EPS(TTM)-1.03
EYN/A
EPS(NY)1.69
Fwd EY12.49%
FCF(TTM)3.87
FCFY28.64%
OCF(TTM)9.66
OCFY71.58%
SpS46.67
BVpS18.8
TBVpS-11.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.44% | ||
| ROE | -5.34% | ||
| ROCE | 7.14% | ||
| ROIC | 5.25% | ||
| ROICexc | 5.71% | ||
| ROICexgc | 22.38% | ||
| OM | 6.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.65% | ||
| FCFM | 8.28% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 5.89 | ||
| Debt/EBITDA | 2.01 | ||
| Cap/Depr | 80.12% | ||
| Cap/Sales | 12.42% | ||
| Interest Coverage | 3.24 | ||
| Cash Conversion | 93.04% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.31 |
F-Score5
WACC4.94%
ROIC/WACC1.06
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-796.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
EPS Next Y-1.48%
EPS Next 2Y20.35%
EPS Next 3Y22.06%
EPS Next 5YN/A
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y121.86%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year283.35%
EBIT Next 3Y64.54%
EBIT Next 5YN/A
FCF growth 1Y87.63%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y23.85%
OCF growth 3Y2%
OCF growth 5Y28.33%
CEGEDIM SA / ALCGM.PA FAQ
What is the ChartMill fundamental rating of CEGEDIM SA (ALCGM.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALCGM.PA.
Can you provide the valuation status for CEGEDIM SA?
ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (ALCGM.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for CEGEDIM SA?
CEGEDIM SA (ALCGM.PA) has a profitability rating of 2 / 10.
How financially healthy is CEGEDIM SA?
The financial health rating of CEGEDIM SA (ALCGM.PA) is 1 / 10.
How sustainable is the dividend of CEGEDIM SA (ALCGM.PA) stock?
The dividend rating of CEGEDIM SA (ALCGM.PA) is 0 / 10 and the dividend payout ratio is 0%.